Alcohol liver diseases;Mise au point: Hépatopathies alcooliques

Gastroenterologie Clinique et Biologique

Volumn 30, Issue 4, 2006, Pages 550-553

  Naveau, Sylvie ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALCOHOL LIVER DISEASE; CLINICAL FEATURE; DRUG EFFICACY; HUMAN; MORPHOLOGY; MORTALITY; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 33744937960     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(06)73224-9     Document Type: Review

References (23)

1. Données sur la situation sanitaire et sociale en France en 2003. Direction de la recherche des études de l'évaluation et des statistiques. Edition 2003.
2. Becker U, Deis A, Sonensen TIA, Gronbaek M, Borch-Johnsen K, Muller CF, Schnohr P, Jensen G. Prediction of risk of liver disease by alcohol intake, sex and age : a prospective population study. Hepatology 1996;23:1025-9.
3. Stranges S, Freudenheim JL, Muti P, Farinaro E, Russell M, Nochajski TH, Trevisan M. Differential effects of alcohol drunking pattern on liver enzymes in men and women. Alcohol Clin Exp Res 2004;28:949-56.
4. Bellantani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria Croce L, Sasso F, Pozzato G, Cristianini G, Brandi G and the Dionysos Study Group. Drinking habits as cofactors of risk for alcohol induced liver damage. Gut 1997;41:845-50.
5. Naveau S, Perrier C, Ink O, Mory B, Poynard T, Chaput JC. Are alcoholic beverages equivalent in their potential to cause alcoholic liver disease ? Eur J Gastroenterol Hepatol 1991;3:265-9.
6. Becker U, Gronberg M, Johansen D, Sorensen TIA. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology 2002;35:868-75.
7. Pelletier S, Vaucher E, Aider R, Martin S, Perney P, Balmes JL, Nalpas B. Wine consumption is not associated with a decreased risk of alcoholic cirrhosis in heavy drinkers. Alcohol 2002;37:618-21.
8. Rotily M, Durbec JP, Berthezene P, Sarles H. Diet and alcohol in liver cirrhosis : a case control study. Eur J Clin Nutr 1990;44:595-603.
9. Corrao G, Ferrari PA, Galatola G. Exploring the role of diet in modifying the effect of known disease determinants : application to risk factors of liver cirrhosis. Am J Epidemiol 1995;142:1136-46.
10. Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005;128:24-32.
11. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JCC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997;25:108-11.
12. Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, Naveau S. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002;35:635-8.
13. Hrubec A, Ommen GS. Evidence of genetic predisposition to alcoholic cirrhosis and psychosis : twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol Clin Exp Res 1981;5:207-15.
14. Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, Beuzen F, Capron F, Thabut D, Munteanu M, Chaput JC, Poynard T. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol 2005;3:167-74.
15. Saadeh S, Younossi ZM, Remer EH, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in non alcoholic fatty liver disease. Gastroenterology 2002;123:745-50.
16. Nousbaum JB, Cadranel JF, Bonnemaison G, Bourlière M, Chiche L, Chor H, Denninger MH, Degos F, Jacquemin E, Le Bail B, Loustaud-Ratti V, Pelletier G, Soyer P, Zins M. Recommandations pour la pratique clinique pour la realisation de la ponction biopsie hépatique. Gastroenterol Clin Biol 2002;26:848-78.
17. Carithers RL, Herlong HF, Diehl AM, Show EW, Combes B, Fallon HJ. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989;110:685-90.
18. Galambos JT. Natural history of alcoholic hepatitis III histological changes. Gastroenterology 1972;63:1026-35.
19. Sorensen TIA, Orholm M, Bentsen KD, Hoybye G, Eghoje K, Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984;2:241-4.
20. Alexander JF, Lishner MW, Galambos JT. Natural history of alcoholic hepatitis. The long term progressis. Am J Gastroenterol 1971;56:515-25.
21. Mathurin P, Mendenhall C, Carithers RL, Ramond MJ, Maddrey WC, Garstide P, Poynard T. Corticosteroids improve short term survival in patients with severe alcoholic hepatitis (AH) : individual data analysis of the last three randomized placebo controlled double blind trials. J Hepatol 2002;36:480-7.
22. Mathurin P, Abdelnour M, Ramond MJ, Carbonell N, Fartoux L, Serfaty L, Valla D, Poupon R, Chaput JC, Naveau S. Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology 2003;38:1363-9.
23. Naveau S, Chollet-Martin S, Dharancy S, Mathurin P, Jouet P, Piquet MA, Obert IF, Broët P, Emilie D for the foie-alcool group of the association française pour l'étude du foie (AFEF). A double-blind randomized controlled trial of Infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004;39:1390-7.